{"nct_id":"NCT00478634","title":"A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer","status":"COMPLETED","status_verified_date":"2012-11","start_date":"2007-05","start_date_type":null,"primary_completion_date":"2009-09","primary_completion_date_type":"ACTUAL","completion_date":"2009-09","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["NVS"]}